Afinion Lipid Panel Test

Product Details: Usage/Application Hospital Test for quantitative determination of albumin, creatinine and albumin/creatinine ratio (ACR) in human urine, used for early identification of renal disease in patients with diabetes and/or hypertension. BENEFITSTIMELY TREATMENT CHANGES The Afinion ACR (albumin, creatinine and albumin/creatinine ratio) detects microalbuminuria in human urine. Microalbuminuria is the first clinical sign of diabetic renal disease and cardiovascular disease. Simple testing for microalbuminuria is extremely efficient as an early indicator of renal failure. SHORT ASSAY TIME IN 5 MINUTES The Afinion ACR test gives you reliable results conveniently available when and where you need them. Patient consultations can be carried out with confidence. The Afinion ACR Test Cartridge contains all reagents necessary for the measurement of albumin, creatinine and albumin/creatinine ratio.

Product Details: Number of Reactions(Preps)/Kit 10 T Brand CTK BioTech Test Type Rapid test Sample human serum, plasma, or whole blood Test time 10 Min Cat No : R0253C The OnSite TORCH Panel Rapid Test is a lateral flow chromatographic immunoassay for the qualitative detection and differentiation of antibodies (IgG and IgM) to Toxoplasma gondii (T. gondii), rubella virus, cytomegalovirus (CMV), herpes simplex virus 1 (HSV-1), and herpes simplex virus 2 (HSV-2) in human serum, plasma, or whole blood. This test is intended to be used by professionals as a screening test and provides a preliminary test result to aid in the diagnosis of infection with T. gondii, rubella virus, CMV, HSV-1 and HSV-2. Any interpretation or use of this preliminary test result must also rely on other clinical findings as well as on the professional judgment of health care providers. Alternative test method(s) should be considered to confirm the test result obtained by this device. Recommended for use: Any person presenting with clinical signs or symptoms consistent with TORCH infection. Women who are pregnant or who are planning to become pregnant Individuals with a compromised immune system The OnSite TORCH Panel Rapid Test detects and differentiates IgG and IgM antibodies for all 5 TORCH infections. In general, a negative test result indicates that the individual is at risk for acquiring a primary infection. A positive IgM result only indicates acute infection, a positive IgM and IgG test indicate acute, late phase infection, and a positive IgG test result only indicates past or chronic infection. The presence of IgM anti-rubella virus or high titers of IgG anti-rubella virus (> 200 IU/mL) are suggestive of acute rubella infection. Lower titers of IgG anti-rubella virus (â?¥ 10-15 IU/mL) are suggestive of previous exposure and protective immunity. An individual with an IgG anti-rubella virus titer less than 10-15 IU/mL is considered to be at risk of acquiring a rubella virus infection. The TORCH Panel Rapid test also differentiates between HSV-1 and HSV-2 antibodies using HSV-1 specific glycoprotein G1 and HSV-2 specific glycoprotein G2. Product Specification : Individually sealed foil pouches containing: One cassette device Two desiccants Plastic droppers Sample diluent (REF SB-R0253, 5 mL/bottle) One package insert (instruction for use)

(1)The One Step Drug Screen Test Panel (Urine) is an immunoassay based on the principle of competitive binding.Drugs which may be present in the urine specimen compete against their respective drug conjugate for binding sites on their specific antibody. (2)During testing,a urine specimen migrates upward by capillary action. A drug, if present in the urine specimen below its cut-off concentration, will not saturate the binding sites of its specific antibody coated on the particles. The antibody coated particles will then be captured by the immobilized drug conjugate and a visible colored line will show up in the test line region of the specific drug strip. The colored line will not form in the test line region if the drug level is above its cut-off concentration because it will saturate all the binding sites of the antibody coated on the particles.

Multi-drug One Step 2-15 Urine Drug Test Cup (MOP, MET, KET, AMP, BAR, BUP, BZO, COC, COT, MDMA, THC, MTD, OPI, PCP, TCA)

Product Details: Instrument Name Biochemistry Analyzer Brand Abbott Usage/Application Hospital Automation Semi Automatic Assays Thyroid, Cardiac, Diabetes Cat. No 1116681 Weight 3.4 Kg Brand Abbott Size 20 cm x 19 cm x 33 cm Display Color Touch Display Connectivity Connectivity Solutions That Support Poct1-A Maintenance No Maintenance Needed S.No Code Pima CD4 Cartridge 1 1116795 Afinion 2 Test Kit - Hb1Ac 2 1116787 Afinion 2 Test Kit - CRP 3 1116781 Afinion 2 Test Kit - ACR 4 1116801 Afinion 2 Test Kit - Lipid Panel Improve the way you diagnose, monitor and manage your patients The Afinion 2 Analyzer is a compact, rapid, multi-assay analyzer that provides valuable near patient testing at the point-of-care. With the Afinion System theres no need to send patients to the lab or spend time tracking down their results. That way you can keep your focus where it belongs on the patient.

The GENEDIA W COVID-19 Ag is an in vitro diagnostic single-use test and qualitative immunoassay to detect SARS-CoV-2 antigen in nasopharyngeal swab and sputum specimen from human. This assay is designed for professional personnel in laboratory and at point-of-care as an aid in screening patients suspected of being infected and asymptomatic patients. Allow wider testing with fast test time (10 minutes) Clinically proven data of asymptomatic patients available Separately packed extraction solution to minimize the possibility of contamination No additional instruments required Package Unit : 20 Tests/Kit Expiration Date : 24 Months (while sealed in the original aluminum foil pouch) GCMS manufactures COVID-19 antigen test kit, the GENEDIA W COVID-19 Ag which is listed on the EU common list, also with GMP and ISO certifications. GENEDIA W COVID-19 Ag is unaffected based on the in-silicon analysis of the mutations in the nucleocapsid (N gene) of Omicron viruses. Letter of statement is available upon your request. To get over COVID-19 pandemic, especially the recent Omicron breakout, currently we are doing big promotions for three kinds of COVID-19 Ag kit. All are in stock and available right away. 1. Nasopharyngeal 2. Nasal 3. Saliva The price is negotiable according to the amount of your order and shipping term. No MOQ is required but we prefer 1 pallet with 9,600 tests. (20 tests/kit, 30 kits/carton, 16 cartons/pallet)

GENEDIA W COVID-19 Ag (Nasal swab) GCMS manufactures COVID-19 antigen test kit, the GENEDIA W COVID-19 Ag which is listed on the EU common list, also with GMP and ISO certifications. GENEDIA W COVID-19 Ag is unaffected based on the in-silicon analysis of the mutations in the nucleocapsid (N gene) of Omicron viruses. Letter of statement is available upon your request. To get over COVID-19 pandemic, especially the recent Omicron breakout, currently we are doing big promotions for three kinds of COVID-19 Ag kit. All are in stock and available right away. 1. Nasopharyngeal 2. Nasal 3. Saliva

General Information Items : MOR/MET/THC/AMP/MDMA/MTD/COC/TCA/BAR/BZO, up to 15 kinds of Drug Tests Format: Strip, Cassette, Cup,and Panel Specimen: Urine Packaging Details: Pouch+Box+Carton packaging (1) With our companyâ??s Logo (2) With the natural package (3) With OEM package (4) ODM Anna Lee Int'l Market Executive SPANBIO T

Product Details: Material Hips Usage/Application Clinical Country of Origin Made in India Sample Volume 2.5 microlitre Brand Abbott model number AFINION CRP Assay time 3 to 4 minutes Sample material Capillary blood,serum,plasma,or anticoagulated venous blood (EDTA or heparin) Measuring range 5-200 mg/L (whole blood),5-160 mg/L (serum and plasma Abbott AFINION CRP Rapid Vitro Diagnostic Test